Molnupiravir is considered a potential antiviral treatment for COVID-19. This recently discovered drug acts to inhibit the replication of the SARS-CoV-2 virus, potentially reducing the severity of infection. Clinical trials indicate that molnupiravir is capable of treating mild to moderate COVID-19 in vulnerable individuals. While further resear… Read More